Profile data is unavailable for this security.
About the company
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
- Revenue in CAD (TTM)17.40m
- Net income in CAD-2.74m
- Incorporated2016
- Employees80.00
- LocationCrescita Therapeutics Inc2805, Place Louis R RenaudLAVAL H7V 0A3CanadaCAN
- Phone+1 (450) 680-4722
- Fax+1 (905) 673-3614
- Websitehttps://www.crescitatherapeutics.com/
Mergers & acquisitions
| Acquired company | CTX:TOR since announced | Transaction value |
|---|---|---|
| Occy Laboratory Inc-Non-Real Estate Business Assets | 35.71% | 657.00k |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Khiron Life Sciences Corp | 16.14m | -30.66m | 9.62m | 310.00 | -- | -- | -- | 0.5961 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
| Voyageur Pharmaceuticals Ltd | 0.00 | -1.53m | 9.76m | -- | -- | 10.33 | -- | -- | -0.0112 | -0.0112 | 0.00 | 0.0068 | 0.00 | -- | -- | -- | -67.92 | -74.47 | -111.56 | -120.92 | -- | -- | -- | -- | 0.0896 | -329.90 | 0.0406 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
| Crescita Therapeutics Inc | 17.40m | -2.74m | 10.93m | 80.00 | -- | 0.6809 | -- | 0.6282 | -0.1409 | -0.1409 | 0.8891 | 0.8371 | 0.7243 | 1.29 | 9.27 | 217,537.50 | -11.40 | -0.2457 | -14.88 | -0.3059 | 55.58 | 63.41 | -15.73 | -0.3518 | 1.68 | -- | 0.0545 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
| Cytophage Technologies Ltd | 0.00 | -7.80m | 12.67m | -- | -- | 2.40 | -- | -- | -0.3779 | -0.3779 | 0.00 | 0.0978 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2374 | -- | -- | -- | -25.88 | -- | -- | -- |
| Willow Biosciences Inc | 2.87m | -7.72m | 12.98m | 19.00 | -- | 66.56 | -- | 4.52 | -0.0604 | -0.0604 | 0.0222 | 0.0014 | 0.4901 | -- | 6.33 | 151,000.00 | -131.79 | -- | -193.14 | -- | -- | -- | -268.91 | -- | 0.756 | -- | 0.9002 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
| Pharmacielo Ltd | 1.62m | -14.15m | 13.18m | 268.00 | -- | -- | -- | 8.14 | -0.0849 | -0.0849 | 0.0097 | -0.032 | 0.0699 | 1.38 | 24.15 | -- | -61.03 | -- | -165.82 | -- | -86.39 | -- | -873.57 | -- | 0.039 | -2.48 | 1.37 | -- | -70.96 | -- | -12.27 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Attitude Gesti�n SGIIC SAas of 30 Jun 2024 | 293.79k | 1.53% |
